Helvetica Swiss Commercial Fund proves to be resilient in financial ...
Successful completion of a record year for Redcare Pharmacy: ...
Helvetica Swiss Living Fund experiences rising tenant demand ...
Helvetica Swiss Opportunity Fund shows net asset value in financial ...
Lubrizol Announces the Appointment of Bhavana Bindra as a Managing ...
Transgene NEC and BostonGene Expand Collaboration for Phase I ...
EQS-CMS: HelloFresh SE: Release of a capital market information ...
Smartbroker Holding AG: André Kolbinger, buy
Smartbroker Holding AG: André Kolbinger, buy
EQS-CMS: BP p.l.c.: Release of a capital market information
Seamless transition for continuity and stability: Redcare Pharmacy ...
Redcare Pharmacy with internal succession plan due to the early ...
Fuller, Smith & Turner PLC: Transaction in Own Shares
PVA TePla AG: Release according to Article 40 Section 1 of the ...
init innovation in traffic systems SE: Transport for London (TfL) ...
EQS-CMS: Samara Asset Group p.l.c.: Release of a capital market ...
NAKIKI SE: Corporate actions completed
KATEK SE: Release according to Article 40 Section 1 of the WpHG ...
Auto1 Group SE: Release according to Article 40 Section 1 of ...
EQS-CMS: CANCOM SE: Release of a capital market information
LANXESS Aktiengesellschaft: Release according to Article 40 Section ...
Signing of a binding merger for the sale of a block of shares ...
WashTec AG: Announcement of dividend proposal
Custodian Property Income REIT plc: Investor Presentation via ...
EQS-CMS: Deutsche Telekom AG: Release of a capital market information ...
EQS-CMS: Cliq Digital AG: Release of a capital market information ...
TUI AG: Release according to Article 40 Section 1 of the WpHG ...
TUI AG: Release according to Article 40 Section 1 of the WpHG ...
EQS-CMS: HomeToGo SE: Release of a capital market information ...
KATEK SE: Receipt of an offer from a PRIMEPULSE SE subsidiary ...
Delivery Hero SE: Release according to Article 40 Section 1 of ...
LfA Förderbank Bayern: Preliminary announcement of the publication ...
SCHOTT Pharma AG & Co. KGaA: Dr. Jens Schulte, sell
MorphoSys AG: Release according to Article 40 Section 1 of the ...
MorphoSys AG: Release according to Article 40 Section 1 of the ...